NETHERLANDS · DRAFT · 27 SEPTEMBER 2026
Netherlands botanical supplement rules 2026: what the draft would change
The Netherlands notified draft amendments under TRIS number 2026/0486/NL. They are not yet in force. A brand planning a Dutch launch can review a future scenario now, without treating a notified proposal as a current product ban.
Draft notification ≠ current Dutch law.
The European Commission TRIS record lists receipt on 4 September 2026 and a standstill end of 7 December 2026. It does not establish an effective date. The draft text contains a transitional formula tied to that unknown date, not a calendar deadline for a brand.
Food supplements and herbal preparations must not be flattened together.
The proposal amends two Dutch decrees. A p-synephrine condition appears for both food supplements and herbal preparations: the draft sets 27 mg per recommended daily intake. Other provisions differ. In the loaded subset, the proposed non-root Withania somnifera prohibition and root consumer advice are scoped to herbal preparations. They are not automatically copied to food supplements.
Article and annex wording, material identity, plant part, preparation and product-category classification all matter. Mutual-recognition questions also require case-specific review; the notification alone is not a general exemption or a guarantee of market access.
The same ingredient name is not enough.
Above the proposed 27 mg/day condition. This is a draft-impact flag, not a finding of current non-compliance.
Plant part and product category match a proposed prohibition in the loaded subset. Verify the material against the original Dutch draft.
A food supplement containing Withania root does not match those two herbal-preparation-only rules in this limited model. That result does not mean it is safe, permitted, or free of other Dutch or EU requirements.
Collect material facts before deciding what to change.
- Confirm whether the Dutch product is a food supplement or herbal preparation.
- Map botanical species, plant part and supplier specification; record daily p-synephrine amount where relevant.
- Compare the specific draft provision with the label and product dossier.
- Track whether the Dutch authority adopts, amends or withdraws the text and establishes an effective date.
Preview a future scenario without rewriting current compliance status.
The prototype checks a curated subset only. Missing facts produce a visible gap; results remain DRAFT · FUTURE SCENARIO.
Original text and notification
European Commission TRIS · 2026/0486/NLNotification, dates, scope and mutual-recognition note ↗Dutch draft text · originalAuthoritative language for wording review ↗English draft text · working translationUseful for orientation; not the decision source ↗Source state checked 27 September 2026. This article covers a curated subset, not every botanical or current Dutch obligation. It is educational information, not legal advice or a marketability determination.